Article
American Journal of Hypertension (2008); 21, 11, 1224–1230. doi:10.1038/ajh.2008.268
Pulse Pressure and Adverse Outcomes in Women: A Report From the Women's Ischemia Syndrome Evaluation (WISE)
R. David Anderson1, B. Clay Sizemore1, Genevieve M. Barrow2, B. Delia Johnson2, C. Noel Bairey Merz3, George Sopko4, Gregory O. von Mering1, Eileen M. Handberg1, Wilmer W. Nichols1 and Carl J. Pepine1
- 1Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
- 2Department of Medical and Clinical Psychology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
- 3Preventive and Rehabilitative Cardiac Center at Cedars-Sinai Medical Center, Cedars-Sinai Medical Center, Los Angeles, California, USA
- 4National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
Correspondence: Carl J. Pepine, (pepincj@medicine.ufl.edu)
Received 28 March 2008; First Decision 3 May 2008; Accepted 31 July 2008; Published online 18 September 2008.
Abstract
Background
Recent data suggest that brachial pulse pressure (PP) may be a better predictor of outcome than systolic or diastolic blood pressure (SBP/DBP). We sought to investigate the relative contributions of these indices to risk for adverse outcomes in women with suspected coronary artery disease (CAD) and myocardial ischemia.
Methods
Among 857 women referred for angiography for suspected myocardial ischemia, baseline evaluations were performed, and the women were followed for clinical outcome. Relationships between baseline characteristics, blood pressure components, and outcomes were evaluated. Separate multivariate stepwise Cox regression models for PP and SBP (expressed in 10 mm Hg increments) were constructed and included covariates significantly associated with adverse outcomes.
Results
After 5.2 years (mean), univariate testing identified higher PP associated with higher risk for cardiovascular (CV) mortality and adverse CV outcomes than SBP, DBP, or mean arterial pressure (MAP). Multivariate modeling identified both PP and SBP associated with adverse CV outcomes, but only PP was significantly associated with higher CV mortality. When both PP and SBP were included in the model, only PP remained an independent predictor of adverse outcomes for CV events.
Conclusions
In women with suspected CAD and myocardial ischemia, PP is a stronger predictor of adverse outcomes than SBP, DBP, or MAP with an 18% excess mortality risk for every 10 mm Hg increase in PP. Further investigations into pathophysiologic mechanisms and specific pharmacologic approaches to modifying this novel target are warranted.
American Journal of Hypertension (2008). doi:10.1038/ajh.2008.268
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic?ischemic ratsJournal of Cerebral Blood Flow & Metabolism Original Article
Is the nitric oxide system involved in genetic hypertension in Dahl rats?Kidney International Original Article
Prognostic application of arterial stiffness: task forcesAmerican Journal of Hypertension Research
See all 15 matches for Research